. 2021 Jun 24;14(6):e238494. doi: 10.1136/bcr-2020-238494
© BMJ Publishing Group Limited 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Figure 1.
Liver lesions prior to commencing on an MEK inhibitor. Lactate dehydrogenase was 2248 IU/L.